Physician Assistant, Medical · Austin, TX
NPI
1861480881
Since 2005
Specialty
Physician Assistant, Medical
Code 363AM0700X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
102 Westlake Dr, Ste 100
Austin, TX, 78746
Phone (512) 327-7779
Groups this clinician bills Medicare through
Medicare paid, 2024
$220K
6,221 services
Medicare patients, 2024
985
Average age 76
Drug cost, 2024
$46K
733 prescriptions
Company payments, 2025
$713
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mellissa Binney was code 17003 (destruction skin lesion), 2,518 times for 446 patients. In total Mellissa Binney billed 6,221 services in 37 codes, and Medicare paid $220K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-10-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 2,518 | 446 | $4.27 | $11K |
| 99214 Office E&M - Established | Office | 1,284 | 857 | $71.78 | $92K |
| 17000 Destruction Skin Lesion | Office | 941 | 622 | $32.36 | $30K |
| 17110 Destruction Skin Lesion | Office | 369 | 287 | $64.79 | $24K |
| 99212 Office E&M - Established | Office | 246 | 206 | $33.32 | $8,196 |
| 11102 Skin Biopsy | Office | 222 | 195 | $50.66 | $11K |
| 99213 Office E&M - Established | Office | 119 | 103 | $52.08 | $6,197 |
| 11301 Removal or Shaving of Skin Growth | Office | 99 | 88 | $69.66 | $6,896 |
| 17004 Destruction Skin Lesion | Office | 48 | 38 | $97.36 | $4,673 |
| 11300 Removal or Shaving of Skin Growth | Office | 47 | 43 | $49.84 | $2,342 |
| 11103 Skin Biopsy | Office | 42 | 39 | $33.66 | $1,414 |
| 10060 Skin | Office | 38 | 34 | $84.25 | $3,202 |
| 99204 Office E&M - New | Office | 35 | 35 | $90.56 | $3,170 |
| 17262 Destruction Skin Lesion | Office | 31 | 25 | $102.53 | $3,178 |
| 11302 Removal or Shaving of Skin Growth | Office | 27 | 23 | $85.20 | $2,300 |
By year: 2022 $228K for 6,289 services; 2023 $206K for 5,867 services; 2024 $220K for 6,221 services.
Medicare prescription drug claims, 2024
In 2024, the drug Mellissa Binney prescribed most often to Medicare patients was Ketoconazole, with 145 prescriptions and refills. In total Mellissa Binney wrote 733 Medicare prescriptions that cost $46K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ketoconazole Generic | 145 | 151 | 74 | $1,801 |
| Triamcinolone Acetonide Generic | 97 | 101 | 83 | $713 |
| Valacyclovir Valacyclovir Hcl | 77 | 89 | 38 | $1,068 |
| Metronidazole Generic | 71 | 85 | 44 | $2,697 |
| Mupirocin Generic | 58 | 58 | 45 | $437 |
| Doxycycline Hyclate Generic | 47 | 50 | 17 | $2,897 |
| Clindamycin Phosphate Generic | 33 | 33 | Under 11 | $397 |
| Clobetasol Propionate Generic | 29 | 29 | 25 | $879 |
| Fluocinonide Generic | 27 | 27 | 21 | $845 |
| Doxycycline Ir-Dr Doxycycline Monohydrate | 26 | 52 | Under 11 | $22K |
| Azelaic Acid Generic | 15 | 15 | Under 11 | $1,390 |
| Hydrocortisone Generic | 11 | 11 | Under 11 | $34.26 |
Brand drugs: 22 claims; generic drugs: 711 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mellissa Binney $713 ($713 in general payments such as food, travel and fees) from 11 companies. The largest payer was UCB, Inc. with $232.
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. UCB.BR | 7 | $232 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 2 | $108 |
| Regeneron Healthcare Solutions, Inc. REGN | 3 | $95.8 |
| Lilly USA, LLC LLY | 3 | $77.73 |
| E.R. Squibb & Sons, L.L.C. BMY | 3 | $57.14 |
| Incyte Corporation INCY | 1 | $28.3 |
| LEO Pharma Inc. | 1 | $27.41 |
| Arcutis Biotherapeutics, Inc. ARQT | 1 | $24.23 |
| Novartis Pharmaceuticals Corporation NVS | 1 | $23.12 |
| LNHC, Inc | 1 | $19.94 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.